Subscribe to RSS
DOI: 10.1055/s-0030-1258029
A Short and Efficient Synthesis of Licochalcone E
Publication History
Publication Date:
12 August 2010 (online)
Abstract
Licochalcone E was synthesized concisely via an abnormal Claisen rearrangement and Claisen-Schmidt condensation as the key reactions in a three-step sequence. The overall yield is 20% starting from prenyl bromide and 4-hydroxy-2-methoxybenzaldehyde.
Key words
licochalcone E - abnormal Claisen rearrangement - Claisen-Schmidt condensation - total synthesis
Licorice is a traditional medicine used in the Northeast Asia for the treatment of gastric and peptic ulcers, bronchial asthma, inflammation and other diseases. [¹] [²] Six retrochalcones, licochalcone A-E and echinatin (Figure [¹] ) have been isolated and characterized from the roots of G. inflata, which is the main species in Chinese Xinjiang licorice. [³-6] These retrochalcones are comprised of two benzene rings joined by an α,β-unsaturated carbonyl system, structurally distinguishable from normal chalcones by the lack of oxygen functionalities at C-2′ and C-6′ positions of A ring. In particular, among many constituents, retrochalcones, chalcones, flavonoids are responsible for the yellow color of licorice. The series of retrochalcones family have shown various biological properties, including antitumor, [³] [7] antiparasitic, [8] antileishmanial, [9] antibacterial activities. [¹0] They also display antioxidative and superoxide scavenging property. [¹¹]
Among the reported retrochalcones, licochalcone E, as a member of this family, was isolated in 2005 by Cheon’s group. [6] The initial biological activity study showed that this compound exhibited a higher cytotoxicity compared to the analogous licochalcone A and isoliquiritigenin. [6] Furthermore, licochalcone E has also been reported to modulate the nuclear factor (NF)-KB and Bc1-2 families and to induce endothelial cell apoptosis. [¹²] Recently, research revealed that licochalcone E inhibited protein tyrosine phosphatase 1B (PTP1B) which played crucial role in negative regulation of insulin and leptin signaling pathways. [¹³]
Due to the demand of large amount of licochalcone E for further biological activity studies and the low isolated yield from natural product (yield: 0.0005% from 1 kg of G. inflate), chemical synthesis of licochalcone E was highly desirable. Several routes to the semi-synthesis or total synthesis of licochalcone E have been reported by Cheon and Na independently in 2009 and 2010. [¹4] These methods, however, suffered from limitations such as tedious protection and deprotection procedure of phenolic hydroxy group, by employing Claisen rearrangement and Claisen-Schmidt condensation reaction as the key steps. For example, as depicted in Scheme [¹] , licochalcone E was obtained in 15% overall yield via at least five steps from the starting material 1-bromo-2-methyl-2E-butene (2), as well as the formation of a side product which was tentatively called licochalcone F was observed. [¹4a]

Figure 1 Structure of the retrochalcones
Our goal was to search for a shorter and more efficient protocol for the synthesis of licochalcone E, and we suspected that this may be achieved by overcoming the shortcoming of the above mentioned synthesis strategies. [¹4a] To our best knowledge, an abnormal Claisen rearrangement as the special rearrangement reaction usually happens after normal Claisen rearrangement of certain allyl vinyl ether without protection of phenolic hydroxy group. [¹5-¹7] Thus, functional allyl groups could be introduced into suitable position directly by the utilization of this reaction. Recently, its contribution to naturally occurring products or relative compounds was explored. [¹8] Additionally, even though Claisen-Schmidt condensation was usually performed under basic conditions, the greater advantage of running the reaction under acidic conditions had been demonstrated in the construction of retrochalcone such as licochalcone A without hydroxy group protection. [¹9] [²0] Therefore, we envisaged that a shorter route may be secured through abnormal Claisen rearrangement and the utilization of acidic conditions in the Claisen-Schmidt condensation.

Scheme 1 Synthesis route of licochalcone E from 1-bromo-2-methyl-2E-butene as reported in the literature. [¹4a] Reagents and conditions: (a) K2CO3, acetone; (b) N,N-dimethylaniline, n-butyric anhydride; (c) (1) 10% NaOH-EtOH; (2) 2 M HCl; (d) THP, PTSA, CH2Cl2; (e) (1) 4-hydroxyacetophenone, NaOH-EtOH; (2) 4 M HCl.
Herein, we present one short and efficient synthesis route to licochalcone E, the reagents and reaction conditions for which are depicted in Scheme [²] . Our journey towards the synthesis of licochalcone E began with prenyl bromide (8) and 4-hydroxy-2-methoxybenzaldehyde (1), and the O-alkenelated ether 9 was formed at room temperature using K2CO3 and anhydrous acetone as solvent in 86% yield. The abnormal Claisen rearrangement reaction proceeded by heating ether 9 to 185 ˚C for 26 hours in anhydrous N,N-dimethylaniline under nitrogen. After cooling to room temperature, the reaction system was neutralized by diluted HCl. The crude product was then extracted with diethyl ether and purified via silica gel chromatography to obtain the key intermediate 5-(1,2-dimethyl-2-propenyl)-4-hydroxy-2-methoxy benzaldehyde (5) in 32% yield, accompanied by the recovery of starting material 1 formed from the decomposition of 9 in 4% yield. Finally, 1.5-2.0 M HCl in anhydrous ethanol was added slowly to a mixture of 5 and 4-hydroxyacetophenone at 0-5 ˚C to promote the Claisen-Schmidt condensation. After workup, the orange-colored title product licochalcone E (7) was obtained in 72% yield after silica gel chromatography.
In comparison to reported literature, [¹4a] herein licochalcone E was synthesized efficiently by a three-step sequence from starting material prenyl bromide and 4-hydroxy-2-methoxybenzaldehyde. The spectral data of intermediate 5 and licochalcone E (7) were consistent with the reported literature values. [6] [¹4] The trans configuration of licochalcone E could also be confirmed by the large coupling constant (J = 15.9 Hz) observed for the olefinic proton signals in its ¹H NMR spectrum.

Scheme 2 Total synthesis route of licochalcone E from prenyl bromide. Reagents and conditions: (a) K2CO3, acetone; (b) N,N-dimethylaniline; (c) 4-hydroxyacetophenone, HCl-EtOH.
A plausible reaction mechanism of the abnormal Claisen rearrangement is shown in Scheme [³] . The initial [3,3]-sigmatropic reaction process produces the normal Claisen rearrangement compound 10 which is not isolable but undergoes tautomerization to form quinone 11. Compound 11 then undergoes an intramolecular oxy-ene reaction to form cyclopropane 13. Subsequently, retro oxy-ene reaction leads to the formation of the abnormal rearrangement product 5.

Scheme 3 The mechanism of abnormal Claisen rearrangement reaction
In summary, we have developed an efficient and short access to licochalcone E via a three-step procedure with an overall yield of 20%. [²¹] This simple and efficient route makes the synthesis of licochalcone E in large scale possible. Furthermore, our result presented herein implies that the synthesis of other analogues of this family may also be carried out via the abnormal Claisen rearrangement reaction. Further biological study of licochalcone E and the synthesis of other modified analogues and derivatives are currently underway in our group.
- Supporting Information for this article is available online:
- Supporting Information
Acknowledgment
This research was supported by funding from the Scientific Forefront and Interdisciplinary Innovation Project, JiLin University (Grant, No 421031531412), P. R. of China.
- 1
Huang KC. The Pharmacology of Chinese Herbs CRC Press; Florida: 1993. p.277 - 2
Asl MN.Hosseinzadeh H. Phytother. Res. 2008, 22: 709 - 3
Saitoh T.Shibata S. Tetrahedron Lett. 1975, 4461 - 4
Ayabe SI.Kobayashi M.Hikichi M.Matsumoto K.Furuya T. Phytochemistry 1980, 19: 2179 - 5
Kajiyama K.Demizu S.Hiraga Y.Kinoshita K.Koyama K.Takahashi K.Tamura Y.Okada K.Kinoshita T. Phytochemistry 1992, 31: 3229 - 6
Yoon G.Jung YD.Cheon SH. Chem. Pharm. Bull. 2005, 53: 694 - 7
Park EJ.Park HR.Lee JS.Kim JW. Planta Med. 1998, 64: 464 - 8
Nielsen SF.Chen M.Theander TG.Kharazmi A.Christensen SB. Bioorg. Med. Chem. Lett. 1995, 5: 449 - 9
Nielsen SF.Christensen SB.Cruciani G.Kharazmi A.Liljefors T. J. Med. Chem. 1998, 41: 4819 - 10
Haraguchi H.Tanimoto K.Tamura Y.Mizutani K.Kinoshita T. Phytochemistry 1998, 48: 125 - 11
Haraguchi H.Ishikawa H.Mizutani K.Tamura Y.Kinoshita T. Bioorg. Med. Chem. 1998, 6: 339 - 12
Chang HJ.Yoon G.Park JS.Kim MH.Back MK.Kim NH.Shin BA.Ahn BW.Cheon SH.Jung YD. Biol. Pharm. Bull. 2007, 30: 2290 - 13
Yoon G.Lee WJ.S N.Cheon SH. Bioorg. Med. Chem. Lett. 2009, 19: 5155 - 14a
Na Y.Cha JH.Yoon HG.Kwon YJ. Chem. Pharm. Bull. 2009, 57: 607 - 14b
Yoon G.Liu Z.Jeong HJ.Cheon SH. Bull. Korean Chem. Soc. 2009, 30: 2959 - 14c
Liu Z.Yoon G.Cheon SH. Tetrahedron 2010, 66: 3165 - 14d
Yoon G.Oak M.Lee J.Cheon SH. Bull. Korean Chem. Soc. 2010, 31: 1085 - 15
Schobert R.Siegfried S.Gordon G.Mulholland D.Nieuwenhuyzen M. Tetrahedron Lett. 2001, 42: 4561 - 16
Roberts RM.Landolt RG. J. Org. Chem. 1966, 31: 2699 - 17
Coombes CL.Moody CJ. J. Org. Chem. 2008, 73: 6758 - 18
Nakamura S.Ishihara K.Yamamoto H. J. Am. Chem. Soc. 2000, 122: 8131 - 19
Xu RS.Wen GL.Jiang SF.Wang CG.Jiang FX.Xie YY.Gao YS. Acta Chim. Sinica 1979, 37: 289 - 20
Kromann H.Larsen M.Boesen T.Schonning K.Nielsen SF. Eur. J. Med. Chem. 2004, 39: 993
References and Notes
Procedures for
the Preparation of Licochalcone E and Selected Spectral Data:
At r.t., K2CO3 (2.8 g, 20.3 mmol) which had
been grinded carefully was added to the stirred solution of 4-hydroxy-2-methoxybenzaldehyde
(2.0 g, 13.2 mmol) in anhyd acetone. Then after 10 min, prenyl bromide (1.80
mL, 15.3 mmol) was added to the reaction mixture by pipette. The
reaction was stirred for 24 h, until it was complete (checked by
TLC). K2CO3 was removed by filtration, and
the solvent was evaporated under vacuum. The crude residue was recrystallized
from PE to generate the white-colored solid compound 9 (2.4
g, yield 86%).
R
f
0.41 (PE-acetone = 10:2).
MS: m/z = 243.2 [M + Na]+. ¹H NMR
(300 MHz, CDCl3): δ = 1.76 (s, 3 H),
1.81 (s, 3 H), 3.89 (s, 3 H), 4.57-4.59 (d, J = 6.9 Hz, 2 H), 5.46-5.51
(t, J = 6.9
Hz, 1 H), 6.46-6.47 (d, J = 2.1
Hz, 1 H), 6.54-6.57 (dd, J = 2.1,
8.7 Hz, 1 H), 7.79-7.82 (d, J = 8.7
Hz, 1 H), 10.29 (s, 1 H). ¹³C NMR (75
MHz, CDCl3): δ = 18.20, 25.79, 55.52,
65.11, 98.56, 106.20, 118.62, 118.86, 130.66, 139.25, 163.50, 165.45,
188.28. IR (KBr): 2970, 2940, 1680, 1620, 1580, 1500, 1450, 1420,
1390, 1310, 1290, 1270, 1200, 1120, 1030, 928, 818, 787, 642, 602
cm-¹. Anal. Calcd for C13H16O3:
C, 70.89; H, 7.32. Found: C, 70.82; H, 7.29.
A solution
of compound 9 (1.0 g, 4.54 mmol) in freshly distilled N,N-dimethylaniline
(5 mL) under nitrogen atmosphere protection was stirred for 26 h
at about 185 ˚C in sealed tube. Then after cooling to r.t.,
the reaction mixture was neutralized by dilute 10% HCl
solution until its pH changed to 5-7. The solution was
extracted with Et2O. The Et2O layer was washed
with sat. NaHCO3 and NaCl solution separately, and then
dried with anhyd MgSO4. The residue obtained after evaporation
of the solvent was separated via silica gel column chromatography
using mixtures of PE and acetone (30:1) as eluent to give the key
intermediate 5 as a white solid (0.32 g,
32%), accompanied by decomposed starting material 4-hydroxy-2-methoxybenzaldehyde
(1; 40 mg, yield: 4%).
R
f
:
0.18 (PE-acetone = 10:2). MS: m/z = 221.3 [M + H]+. ¹H NMR
(300 MHz, CDCl3): δ = 1.41-1.44
(d, J = 7.2 Hz, 3 H), 1.63 (s,
3 H), 3.46-3.53 (q, J = 7.2
Hz, 1 H), 3.86 (s, 3 H), 5.07 (s, 1 H), 5.16 (s, 1 H), 6.40 (s,
1 H), 6.43 (s, 1 H), 7.66 (s, 1 H), 10.29 (s, 1 H). ¹³C
NMR (75 MHz, CDCl3): δ = 18.27,
20.66, 41.50, 55.65, 99.58, 111.96, 118.36, 122.31, 129.32, 149.64,
162.32, 162.76, 188.76. UV: λmax (EtOH; log ε) = 278
(0.32), 235 (0.46), 206 (0.43) nm. IR (KBr): 3180, 1660, 1590, 1510,
1450, 1380, 1285, 1253, 1120, 1020, 891, 841, 694, 594 cm-¹.
Anal. Calcd for C13H16O3: C, 70.89;
H, 7.32. Found: C, 70.90; H, 7.33.
4-Hydroxyacetophenone
(0.27 g, 2 mmol) and intermediate 5 (0.40
g, 1.82 mmol) were dissolved in anhyd EtOH (2 mL), cooled by ice-water
bath, then anhyd 1.5-2.0 M HCl-EtOH (5 mL) was
added slowly to the stirred solution. The mixture was continuously
stirred for 2 h at 0-5 ˚C until the reaction was
finished completely (checked by TLC). HCl and EtOH solvent were
removed under vacuum; the mixture was then extracted with EtOAc,
washed with H2O, sat. NaHCO3, then H2O
separately. The extracted layer was dried over MgSO4, filtered,
and the solvent was removed under vacuum. Then the title compound
licochalcone E (7) was obtained as an orange
solid (0.45 g, yield 72%) over silica gel column using mixtures
of PE and acetone (10:1) as eluent.:
Licochalcone E also
may be purified according to the following method: theg orange solid
was precipitated completely after cooled H2O was added
slowly to the reaction mixture. The precipitated solid was then
filtered, and recrystallized from cold EtOH-H2O
to provide the target compound.
R
f
: 0.10 (PE-acetone = 10:4).
MS: m/z = 337.3 [M + H]+. ¹H NMR
(300 MHz, CDCl3): δ = 1.45-1.47
(d, J = 7.2 Hz, 3 H), 1.69 (s,
3 H), 3.47-3.54 (q, J = 7.2
Hz, 1 H), 3.88 (s, 3 H), 5.09 (s, 1 H), 5.16 (s, 1 H), 5.67 (s,
1 H), 6.06 (s, 1 H), 6.43 (s, 1 H), 6.92-6.95 (d, J = 9.0 Hz, 2 H), 7.37 (s, 1
H), 7.53-7.59 (d, J = 15.9
Hz, 1 H), 7.99-8.02 (d, J = 9.0
Hz, 2 H), 7.99-8.04 (d, J = 15.9
Hz, 1 H). ¹³C NMR (75 MHz, CD3OD): δ = 19.79,
22.54, 38.97, 56.09, 99.59, 110.16, 116.31, 116.48, 119.29, 125.74,
129.91, 131.44, 132.07, 141.98, 150.39, 160.38, 160.51, 163.52,
191.79. UV: λmax (EtOH; log ε) = 379
(1.33), 309 (0.94), 262 (0.84) nm. IR (KBr): 3400, 2970, 1640, 1600,
1560, 1500, 1450, 1410, 1340, 1290, 1210, 1170, 1120, 1040, 984,
895, 837, 756, 638, 611, 575 cm-¹.
Anal. Calcd for C21H22O4: C, 74.54;
H, 6.55. Found: C, 74.52; H, 6.56.
- 1
Huang KC. The Pharmacology of Chinese Herbs CRC Press; Florida: 1993. p.277 - 2
Asl MN.Hosseinzadeh H. Phytother. Res. 2008, 22: 709 - 3
Saitoh T.Shibata S. Tetrahedron Lett. 1975, 4461 - 4
Ayabe SI.Kobayashi M.Hikichi M.Matsumoto K.Furuya T. Phytochemistry 1980, 19: 2179 - 5
Kajiyama K.Demizu S.Hiraga Y.Kinoshita K.Koyama K.Takahashi K.Tamura Y.Okada K.Kinoshita T. Phytochemistry 1992, 31: 3229 - 6
Yoon G.Jung YD.Cheon SH. Chem. Pharm. Bull. 2005, 53: 694 - 7
Park EJ.Park HR.Lee JS.Kim JW. Planta Med. 1998, 64: 464 - 8
Nielsen SF.Chen M.Theander TG.Kharazmi A.Christensen SB. Bioorg. Med. Chem. Lett. 1995, 5: 449 - 9
Nielsen SF.Christensen SB.Cruciani G.Kharazmi A.Liljefors T. J. Med. Chem. 1998, 41: 4819 - 10
Haraguchi H.Tanimoto K.Tamura Y.Mizutani K.Kinoshita T. Phytochemistry 1998, 48: 125 - 11
Haraguchi H.Ishikawa H.Mizutani K.Tamura Y.Kinoshita T. Bioorg. Med. Chem. 1998, 6: 339 - 12
Chang HJ.Yoon G.Park JS.Kim MH.Back MK.Kim NH.Shin BA.Ahn BW.Cheon SH.Jung YD. Biol. Pharm. Bull. 2007, 30: 2290 - 13
Yoon G.Lee WJ.S N.Cheon SH. Bioorg. Med. Chem. Lett. 2009, 19: 5155 - 14a
Na Y.Cha JH.Yoon HG.Kwon YJ. Chem. Pharm. Bull. 2009, 57: 607 - 14b
Yoon G.Liu Z.Jeong HJ.Cheon SH. Bull. Korean Chem. Soc. 2009, 30: 2959 - 14c
Liu Z.Yoon G.Cheon SH. Tetrahedron 2010, 66: 3165 - 14d
Yoon G.Oak M.Lee J.Cheon SH. Bull. Korean Chem. Soc. 2010, 31: 1085 - 15
Schobert R.Siegfried S.Gordon G.Mulholland D.Nieuwenhuyzen M. Tetrahedron Lett. 2001, 42: 4561 - 16
Roberts RM.Landolt RG. J. Org. Chem. 1966, 31: 2699 - 17
Coombes CL.Moody CJ. J. Org. Chem. 2008, 73: 6758 - 18
Nakamura S.Ishihara K.Yamamoto H. J. Am. Chem. Soc. 2000, 122: 8131 - 19
Xu RS.Wen GL.Jiang SF.Wang CG.Jiang FX.Xie YY.Gao YS. Acta Chim. Sinica 1979, 37: 289 - 20
Kromann H.Larsen M.Boesen T.Schonning K.Nielsen SF. Eur. J. Med. Chem. 2004, 39: 993
References and Notes
Procedures for
the Preparation of Licochalcone E and Selected Spectral Data:
At r.t., K2CO3 (2.8 g, 20.3 mmol) which had
been grinded carefully was added to the stirred solution of 4-hydroxy-2-methoxybenzaldehyde
(2.0 g, 13.2 mmol) in anhyd acetone. Then after 10 min, prenyl bromide (1.80
mL, 15.3 mmol) was added to the reaction mixture by pipette. The
reaction was stirred for 24 h, until it was complete (checked by
TLC). K2CO3 was removed by filtration, and
the solvent was evaporated under vacuum. The crude residue was recrystallized
from PE to generate the white-colored solid compound 9 (2.4
g, yield 86%).
R
f
0.41 (PE-acetone = 10:2).
MS: m/z = 243.2 [M + Na]+. ¹H NMR
(300 MHz, CDCl3): δ = 1.76 (s, 3 H),
1.81 (s, 3 H), 3.89 (s, 3 H), 4.57-4.59 (d, J = 6.9 Hz, 2 H), 5.46-5.51
(t, J = 6.9
Hz, 1 H), 6.46-6.47 (d, J = 2.1
Hz, 1 H), 6.54-6.57 (dd, J = 2.1,
8.7 Hz, 1 H), 7.79-7.82 (d, J = 8.7
Hz, 1 H), 10.29 (s, 1 H). ¹³C NMR (75
MHz, CDCl3): δ = 18.20, 25.79, 55.52,
65.11, 98.56, 106.20, 118.62, 118.86, 130.66, 139.25, 163.50, 165.45,
188.28. IR (KBr): 2970, 2940, 1680, 1620, 1580, 1500, 1450, 1420,
1390, 1310, 1290, 1270, 1200, 1120, 1030, 928, 818, 787, 642, 602
cm-¹. Anal. Calcd for C13H16O3:
C, 70.89; H, 7.32. Found: C, 70.82; H, 7.29.
A solution
of compound 9 (1.0 g, 4.54 mmol) in freshly distilled N,N-dimethylaniline
(5 mL) under nitrogen atmosphere protection was stirred for 26 h
at about 185 ˚C in sealed tube. Then after cooling to r.t.,
the reaction mixture was neutralized by dilute 10% HCl
solution until its pH changed to 5-7. The solution was
extracted with Et2O. The Et2O layer was washed
with sat. NaHCO3 and NaCl solution separately, and then
dried with anhyd MgSO4. The residue obtained after evaporation
of the solvent was separated via silica gel column chromatography
using mixtures of PE and acetone (30:1) as eluent to give the key
intermediate 5 as a white solid (0.32 g,
32%), accompanied by decomposed starting material 4-hydroxy-2-methoxybenzaldehyde
(1; 40 mg, yield: 4%).
R
f
:
0.18 (PE-acetone = 10:2). MS: m/z = 221.3 [M + H]+. ¹H NMR
(300 MHz, CDCl3): δ = 1.41-1.44
(d, J = 7.2 Hz, 3 H), 1.63 (s,
3 H), 3.46-3.53 (q, J = 7.2
Hz, 1 H), 3.86 (s, 3 H), 5.07 (s, 1 H), 5.16 (s, 1 H), 6.40 (s,
1 H), 6.43 (s, 1 H), 7.66 (s, 1 H), 10.29 (s, 1 H). ¹³C
NMR (75 MHz, CDCl3): δ = 18.27,
20.66, 41.50, 55.65, 99.58, 111.96, 118.36, 122.31, 129.32, 149.64,
162.32, 162.76, 188.76. UV: λmax (EtOH; log ε) = 278
(0.32), 235 (0.46), 206 (0.43) nm. IR (KBr): 3180, 1660, 1590, 1510,
1450, 1380, 1285, 1253, 1120, 1020, 891, 841, 694, 594 cm-¹.
Anal. Calcd for C13H16O3: C, 70.89;
H, 7.32. Found: C, 70.90; H, 7.33.
4-Hydroxyacetophenone
(0.27 g, 2 mmol) and intermediate 5 (0.40
g, 1.82 mmol) were dissolved in anhyd EtOH (2 mL), cooled by ice-water
bath, then anhyd 1.5-2.0 M HCl-EtOH (5 mL) was
added slowly to the stirred solution. The mixture was continuously
stirred for 2 h at 0-5 ˚C until the reaction was
finished completely (checked by TLC). HCl and EtOH solvent were
removed under vacuum; the mixture was then extracted with EtOAc,
washed with H2O, sat. NaHCO3, then H2O
separately. The extracted layer was dried over MgSO4, filtered,
and the solvent was removed under vacuum. Then the title compound
licochalcone E (7) was obtained as an orange
solid (0.45 g, yield 72%) over silica gel column using mixtures
of PE and acetone (10:1) as eluent.:
Licochalcone E also
may be purified according to the following method: theg orange solid
was precipitated completely after cooled H2O was added
slowly to the reaction mixture. The precipitated solid was then
filtered, and recrystallized from cold EtOH-H2O
to provide the target compound.
R
f
: 0.10 (PE-acetone = 10:4).
MS: m/z = 337.3 [M + H]+. ¹H NMR
(300 MHz, CDCl3): δ = 1.45-1.47
(d, J = 7.2 Hz, 3 H), 1.69 (s,
3 H), 3.47-3.54 (q, J = 7.2
Hz, 1 H), 3.88 (s, 3 H), 5.09 (s, 1 H), 5.16 (s, 1 H), 5.67 (s,
1 H), 6.06 (s, 1 H), 6.43 (s, 1 H), 6.92-6.95 (d, J = 9.0 Hz, 2 H), 7.37 (s, 1
H), 7.53-7.59 (d, J = 15.9
Hz, 1 H), 7.99-8.02 (d, J = 9.0
Hz, 2 H), 7.99-8.04 (d, J = 15.9
Hz, 1 H). ¹³C NMR (75 MHz, CD3OD): δ = 19.79,
22.54, 38.97, 56.09, 99.59, 110.16, 116.31, 116.48, 119.29, 125.74,
129.91, 131.44, 132.07, 141.98, 150.39, 160.38, 160.51, 163.52,
191.79. UV: λmax (EtOH; log ε) = 379
(1.33), 309 (0.94), 262 (0.84) nm. IR (KBr): 3400, 2970, 1640, 1600,
1560, 1500, 1450, 1410, 1340, 1290, 1210, 1170, 1120, 1040, 984,
895, 837, 756, 638, 611, 575 cm-¹.
Anal. Calcd for C21H22O4: C, 74.54;
H, 6.55. Found: C, 74.52; H, 6.56.

Figure 1 Structure of the retrochalcones

Scheme 1 Synthesis route of licochalcone E from 1-bromo-2-methyl-2E-butene as reported in the literature. [¹4a] Reagents and conditions: (a) K2CO3, acetone; (b) N,N-dimethylaniline, n-butyric anhydride; (c) (1) 10% NaOH-EtOH; (2) 2 M HCl; (d) THP, PTSA, CH2Cl2; (e) (1) 4-hydroxyacetophenone, NaOH-EtOH; (2) 4 M HCl.

Scheme 2 Total synthesis route of licochalcone E from prenyl bromide. Reagents and conditions: (a) K2CO3, acetone; (b) N,N-dimethylaniline; (c) 4-hydroxyacetophenone, HCl-EtOH.

Scheme 3 The mechanism of abnormal Claisen rearrangement reaction